Skip to content

Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKA

Multi-center, Prospective, Clinical Evaluation of the P.F.C.® Sigma™ Rotating Platform Cruciate Substituting vs P.F.C.® Sigma™ Cruciate Substituting Knee Primary Cases

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00289107
Enrollment
149
Registered
2006-02-09
Start date
2001-04-01
Completion date
2007-11-01
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis, Juvenile Rheumatoid Arthritis, Osteoarthritis, Other Inflammatory Arthritis, Post-Traumatic Arthritis, Rheumatoid Arthritis

Keywords

Total Knee Replacement, Knee Prosthesis

Brief summary

The study will evaluate the clinical performance of the rotating platform and fixed bearing implants through patient questionnaires, outcomes scoring and radiographic assessment.

Detailed description

The study will evaluate the clinical performance of rotating platform and fixed bearing cruciate ligament substituting implants by obtaining a series of primary TKAS. Patients will receive either the P.F.C.® Sigma™ Rotating Platform Cruciate Substituting Knee System or P.F.C.® Sigma™ Fixed Cruciate Substituting Knee System and assignment is randomized.

Interventions

DEVICETotal Knee Arthroplasty

Rotating Platform (RP) Cruciate Substituting Knee System

DEVICETotal knee replacement

Fixed Cruciate Substituting Knee System

Sponsors

DePuy Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Osteoarthritis * Rheumatoid arthritis * Other inflammatory arthritis * Avascular necrosis (AVN) of bone * Post-Traumatic Arthritis * Juvenile Rheumatoid Arthritis

Exclusion criteria

* History of recent/active joint sepsis. * Charcot neuropathy. * Psycho-social disorders that would limit rehabilitation. * Greater than 75 years of age at the time of surgery. * Prior ipsilateral knee arthroplasty. * Metabolic disorders of calcified tissues, such as Paget's disease. * Severe diabetes mellitus. * Joint replacement due to autoimmune disorders. * Skeletal immaturity

Design outcomes

Primary

MeasureTime frameDescription
Knee Society ScorePre-operative, 6 and 12 months and annually thereafter for at least 5 years.The Knee Society Score (KSS) is comprised to two sections (each worth 100 points) for a maximum 200 points. One section is the Knee Society Clinical Score (KSCS) - points are given for pain, motion, and stability and points are deducted for flexion contracture, extension lag, and misalignment. The other section is the Knee Society Functional Score (KSFS) - points are assigned for walking distances and climbing stairs and points are deducted for use of walking aids. For each section, a score of 80-100 = excellent, 70-79 = good; 60-69 = fair; and \< 60 = poor.

Secondary

MeasureTime frame
ComplicationsOn-going to end of study
RevisionsOn-going to end of study
Medical ImagingPre-operative, 6 and 12 months and annually thereafter for at least 5 years.
SF-12 Patient OutcomesPre-operative, 6 and 12 months and annually thereafter for at least 5 years.

Countries

United States

Participant flow

Recruitment details

Between April 2001 and October 2002, 106 subjects were recruited and enrolled at 3 US clinics by orthopaedic surgeons. Each study site could enroll up to 50 subjects (cohorts were re-assigned as necessary to complete enrollment in a timely manner). Recruitment was based on the inclusion and exclusion criteria in the clinical investigation plan.

Pre-assignment details

Immediately before surgery, the implant type was determined according to the randomization schedule. Before treatment assignment, consented subjects could be excluded from the trial based on results of pre-operative clinical evaluations and/or radiographs, as per the exclusion criteria in the clinical investigation plan.

Participants by arm

ArmCount
Rotating Platform
P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System has a modular polyethylene insert that is free to rotate around a central pivot point during knee motion.
77
Fixed Bearing
P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System implant has a modular polyethylene insert that is intraoperatively locked into position on the metal tibial base.
72
Total149

Baseline characteristics

CharacteristicRotating PlatformFixed BearingTotal
Age, Continuous64.5 years
STANDARD_DEVIATION 6.3
65.5 years
STANDARD_DEVIATION 7.2
65.0 years
STANDARD_DEVIATION 6.8
Region of Enrollment
United States
United States
77 Participants72 Participants149 Participants
Sex: Female, Male
Female
48 Participants55 Participants103 Participants
Sex: Female, Male
Male
29 Participants17 Participants46 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
6 / 778 / 72
serious
Total, serious adverse events
15 / 776 / 72

Outcome results

Primary

Knee Society Score

The Knee Society Score (KSS) is comprised to two sections (each worth 100 points) for a maximum 200 points. One section is the Knee Society Clinical Score (KSCS) - points are given for pain, motion, and stability and points are deducted for flexion contracture, extension lag, and misalignment. The other section is the Knee Society Functional Score (KSFS) - points are assigned for walking distances and climbing stairs and points are deducted for use of walking aids. For each section, a score of 80-100 = excellent, 70-79 = good; 60-69 = fair; and \< 60 = poor.

Time frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.

ArmMeasureGroupValue (MEAN)Dispersion
Rotating PlatformKnee Society Score12 Months96.1 Scores on a scaleStandard Deviation 6.6
Rotating PlatformKnee Society Score36 Months97.2 Scores on a scaleStandard Deviation 5.2
Rotating PlatformKnee Society Score6 Months90.8 Scores on a scaleStandard Deviation 13.8
Rotating PlatformKnee Society Score48 Months95.8 Scores on a scaleStandard Deviation 5.9
Rotating PlatformKnee Society Score24 Months96.8 Scores on a scaleStandard Deviation 7.6
Rotating PlatformKnee Society Score60 Months93.6 Scores on a scaleStandard Deviation 9
Rotating PlatformKnee Society ScorePre-operative39.3 Scores on a scaleStandard Deviation 15.8
Fixed BearingKnee Society Score60 Months93.5 Scores on a scaleStandard Deviation 8.9
Fixed BearingKnee Society ScorePre-operative37.2 Scores on a scaleStandard Deviation 16.5
Fixed BearingKnee Society Score6 Months89.2 Scores on a scaleStandard Deviation 13.9
Fixed BearingKnee Society Score12 Months93.0 Scores on a scaleStandard Deviation 9.9
Fixed BearingKnee Society Score24 Months96.0 Scores on a scaleStandard Deviation 7.9
Fixed BearingKnee Society Score36 Months94.3 Scores on a scaleStandard Deviation 9.9
Fixed BearingKnee Society Score48 Months93.7 Scores on a scaleStandard Deviation 9.2
Secondary

Complications

Time frame: On-going to end of study

Secondary

Medical Imaging

Time frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.

Secondary

Revisions

Time frame: On-going to end of study

Secondary

SF-12 Patient Outcomes

Time frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026